432 Nemvaleukin alfa, a novel engineered IL-2 cytokine, in combination with the anti-PD-1 antibody pembrolizumab in patients with recurrent/metastatic head and neck squamous cell carcinoma (ION-01 study)
oleh: Yan Wang, Manish Patel, Marshall Posner, Leonard D’Amico, Steven Fling, Brian Gastman, Mac Cheever, Cesar Perez, Yangchun Du, Conor Steuer, Jessica Geiger, Zujun Li, Angela Shaulov Kask, Derek Matthies, Sung Jin Huh, Julie Graham, Laura Chow
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-11-01 |
Deskripsi
No description available for this item.